Perrigo Company plc Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent
Perrigo Company plc (PRGO) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent of -$3.50 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent · last filed 2018-03-01
- Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for fiscal 2017 was -$3.50M, a 266.67% decline from fiscal 2016.
- Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for fiscal 2016 was $2.10M.
- Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for fiscal 2015 was $5.70M.
- Perrigo Company plc other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for fiscal 2014 was -$1.20M, a 137.50% decline from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 6 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|
| 2017-12-31 | -$3.50M 10-K · filed 2018-03-01 | |||
| 2016-12-31 | $2.10M 10-K · filed 2018-03-01 | |||
| 2015-12-31 | -$400.00K 10-K · filed 2018-03-01 | $400.00K 10-KT · filed 2016-02-25 | ||
| 2015-06-27 | $5.70M 10-K · filed 2018-03-01 | -$5.70M 10-K · filed 2015-08-13 | ||
| 2014-06-28 | -$1.20M 10-K · filed 2017-05-22 | |||
| 2013-06-29 | $3.20M 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |